Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Acute Treatment

What is the purpose of this trial?

This study will test the effectiveness and relative efficacy of behavioral and pharmacologic treatments, alone and in combination, for the treatment of binge eating disorder (BED) in patients with obesity. This is an acute treatment comparing behavioral weight loss alone or in combination with naltrexone/bupropion medication.

Participation Guidelines

Ages: 18 - 70 years

Gender: Both

National Institutes of Health

Start Date: 02/27/2017

End Date: 09/30/2023

Last Updated: 02/22/2018

Study HIC#: 1506016065

Get Involved

For more information about this study, contact:
Janet Lydecker
+1 203-737-4299

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email or call 1-877-978-8348.

Trial Image


Carlos Grilo

Principal Investigator